Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader
headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases and Neuroscience. We also make targeted R&D investments in PlasmaDerived Therapies and Vaccines. Takeda Pharmaceutical Company Limited is a global, values-based, R&D-driven biopharmaceutical leader committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines.
Main tasks in the project:
- In WP1, TPIZ will act as the Industry co-lead and assist with consortium management activities.
- In WP2, TPIZ will contribute to the design of the study protocols and assist with the statistical data analysis and patient engagement.
- In WP5 and WP7, TPIZ will support the device specific data analytics and the statistical inference activities.
- In WP8, TPIZ will contribute to the associated regulatory issues.
- TPIZ will also provide assistance to all other WPs.
- TPIZ has taken over these tasks from Partner 36 (TAK).
